Watch Live

Tweet TWEET

MORE: Novartis Says Oncology Head Herve Hoppenot to Leave

NOTE: Novartis Oncology is developing a promising new cancer therapy that faces challenges with how to administer and commercialize * NOTE: Earlier, Novartis Says Oncology Head Herve Hoppenot to Leave

To contact the reporter on this story: Andy Hoffman in Geneva at ahoffman31@bloomberg.net

To contact the editor responsible for this story: Mike Harrison at mharrison5@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.